Association of Gene Polymorphisms in β1-adrenergic Receptor and Angiotension Ⅱ-1 Receptor with Hypertension in Alpine Areas
Division Ⅰof Department of Cardiology,the First Affiliated Hospital of Jiamusi University,Jiamusi 154007,China
*Corresponding author:YANG Jun,Professor;E-mail:13845400055@126.com
WANG Jing,DONG Tianwei,WANG Shuang, et al. Association of Gene Polymorphisms in β1-adrenergic Receptor and Angiotension Ⅱ-1 Receptor with Hypertension in Alpine Areas [J]. Chinese General Practice, 2020, 23(30): 3823-3828. DOI: 10.12114/j.issn.1007-9572.2020.00.237.
王晶,董天崴,王爽等. β1-肾上腺素受体、血管紧张素Ⅱ-1型受体基因多态性与高寒地区高血压的关系研究[J]. 中国全科医学, 2020, 23(30): 3823-3828. DOI: 10.12114/j.issn.1007-9572.2020.00.237.
[1]郑冬银.高血压个体化用药基因检测[J].海峡药学,2018,30(8):252-254.DOI:10.3969/j.issn.1006-3765.2018.08.141.
[2]封锐,王林,王罗莎.气象对心血管病影响的研究现状[J].天津医药,2013,41(3):282-284.DOI:10.3969/j.issn.0253-9896.2013.03.032.
[3]中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志,2011,39(7):579-616.DOI:10.3760/cma.j.issn.0253-3758.2011.07.002.
[4]徐慧.原发性高血压病中医证型与高血压药物基因多态性的相关性研究[D].北京:北京中医药大学,2018.
[5]刘洁,刘昭前,刘英姿.β1肾上腺素受体与CYP2D6基因多态性对美托洛尔抗高血压治疗的药代动力学和药效学影响[J].中国临床药理学与治疗学,2007,12(10):1130-1137.DOI:10.3969/j.issn.1009-2501.2007.10.006.
LIU J,LIU Z Q,LIU Y Z,et al.Effects of β1-adrenergic receptor and CYP2D6 genetic polymorphism on metoprolol pharmacokinetics and pharmacodynamics in antihypertension therapy[J].Chinese Journal of Clinical Pharmacology and Therapeutics,2007,12(10):1130-1137.DOI:10.3969/j.issn.1009-2501.2007.10.006.
[6]钟萍.β-AR基因多态性与EH的关联性及其与职业精神应激交互作用在EH高发人群中的致病作用[D].福州:福建医科大学,2009.
ZHONG P.B-adrenergic receptor polymorphisms,occupational mental stress and their interaction involved in the pathogenesis of EH in the high risk population[D].Fuzhou:Fujian Medical University,2009.
[7]ARNOLD A S,TANG Y L,QIAN K P,et al.Specific beta1-adrenergic receptor silencing with small interfering RNA lowers high blood pressure and improves cardiac function in myocardial ischemia[J].J Hypertens,2007,25(1):197-205.DOI:10.1097/01.hjh.0000254374.73241.ab.
[8]LIU J,LIU Z Q,TAN Z R,et al.Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol[J].Clin Pharmacol Ther,2003,74(4):372-379.DOI:10.1016/S0009-9236(03)00224-8.
[9]PENG Y X,XUE H,LUO L M,et al.Polymorphisms of the beta1-adrenergic receptor gene are associated with essential hypertension in Chinese[J].Clin Chem Lab Med,2009,47(10):1227-1231.DOI:10.1515/CCLM.2009.276.
[10]李俊萍,郭晓华,郑玉云,等.β1肾上腺素能受体Gly389Arg多态性与原发性高血压的关系[J].国际心血管病杂志,2006,33(4):275-277.
[11]李强,杨新春,张麟.β1-肾上腺素能受体基因多态性与原发性高血压易感性[J].中华心血管病杂志,2004,32(z1):445.DOI:10.3760/j:issn:0253-3758.2004.z1.385.
[12]牛永红,谢正祥,殷跃辉.β肾上腺素能受体基因多态性与原发性高血压的关系[J].中国组织工程研究与临床康复,2007,11(12):2243-2246.DOI:10.3321/j.issn:1673-8225.2007.12.031.
NIU Y H,XIE Z X,YIN Y H.Beta-adrenoceptor gene polymorphism and essential hypertension[J].Journal of Clinical Rehabilitative Tissue Engineering Research,2007,11(12):2243-2246.DOI:10.3321/j.issn:1673-8225.2007.12.031.
[13]WANG H,LIU J L,LIU K,et al.Β1-adrenoceptor gene Arg389Gly polymorphism and essential hypertension risk in general population:a meta-analysis[J].Mol Biol Rep,2013,40(6):4055-4063.DOI:10.1007/s11033-012-2483-1.
[14]梁宇,赵彦艳,刘洪,等.β肾上腺素能受体基因家族在中国东北高血压病高发人群中的基因型分析[J].中华医学遗传学杂志,2004,21(2):124-127.DOI:10.3760/j.issn:1003-9406.2004.02.007.
LIANG Y,ZHAO Y Y,LIU H,et al.The genotype analysis of β adrenergic receptor gene family in high risk population of hypertension in northeast China[J].Chinese Journal of Medical Genetics,2004,21(2):124-127.DOI:10.3760/j.issn:1003-9406.2004.02.007.
[15]余惠珍,白玉茹,陈慧.AT1R基因和ACE基因多态性与高血压病的相关性分析[J].高血压杂志,1999,7(4):319.DOI:10.3969/j.issn.1673-7245.1999.04.014.
[16]孟超,陆惠华,方宁远,等.老年原发性高血压患者AT1-R基因A1166C多态性及降压药物对其的影响[J].高血压杂志,2002,10(4):347-351.DOI:10.3969/j.issn.1673-7245.2002.04.014.
MENG C,LU H H,FANG N Y,et al.The A1166C polymorphism of the Angiotensin Ⅱ type Ⅰ receptor gene and the response to antihypertensive agents in the elderly[J].Chinese Journal of Hypertension,2002,10(4):347-351.DOI:10.3969/j.issn.1673-7245.2002.04.014.
[17]KOOFFREH M E,ANUMUDU C I,DUKE R,et al.Angiotensin Ⅱ type 1 receptor A1166C gene polymorphism and essential hypertension in Calabar and Uyo cities,Nigeria[J].Indian J Hum Genet,2013,19(2):213-218.DOI:10.4103/0971-6866.116120.
[18]李涛,李南方,周玲,等.新疆哈萨克族人群中血管紧张素Ⅱ-1型受体基因多态性与原发性高血压的相关性研究[J].临床心血管病杂志,2008,24(8):606-608.DOI:10.3969/j.issn.1001-1439.2008.08.018.
LI T,LI N F,ZHOU L,et al.Study for relationship between the angiotensin Ⅱ type 1 receptor gene polymorphism and essential hypertension in Kazakans of Xinjiang[J].Journal of Clinical Cardiology,2008,24(8):606-608.DOI:10.3969/j.issn.1001-1439.2008.08.018.
[19]STANKOVIC A,ZIVKOVIC M,GLISIC S,et al.Angiotensin Ⅱ type 1 receptor gene polymorphism and essential hypertension in Serbian population[J].Clin Chim Acta,2003,327(1/2):181-185.DOI:10.1016/s0009-8981(02)00340-6.
[20]LIU D X,ZHANG Y Q,HU B,et al.Association of AT1R polymorphism with hypertension risk:an update meta-analysis based on 28,952 subjects[J].J Renin Angiotensin Aldosterone Syst,2015,16(4):898-909.DOI:10.1177/1470320315584096.
[21]何青芳,俞敏,王立新.血管紧张素Ⅱ-1型受体基因多态性与原发性高血压的相关性研究[J].中华检验医学杂志,2006,29(9):818-819.